Literature DB >> 10884581

NMR imaging investigations of drug delivery devices using a flow-through USP dissolution apparatus.

C A Fyfe1, H Grondey, A I Blazek-Welsh, S K Chopra, B J Fahie.   

Abstract

A system for performing NMR imaging experiments on drug delivery devices within a flow-through dissolution apparatus, USP Apparatus 4, has been developed. The system was used to image the physical changes that occur in solid dosage forms during dissolution in the flow-through apparatus. Simultaneous cumulative drug release measurements were also made. The NMR images obtained under these conditions and the drug release data provide a better understanding of the processes involved in the release of drugs from drug delivery systems based on diffusion, dissolution and osmosis mechanisms.

Mesh:

Substances:

Year:  2000        PMID: 10884581     DOI: 10.1016/s0168-3659(00)00237-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  4 in total

1.  Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations.

Authors:  Przemyslaw P Dorozyński; Piotr Kulinowski; Aleksander Mendyk; Anna Młynarczyk; Renata Jachowicz
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

2.  Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release.

Authors:  Sergei G Kazarian; Jaap van der Weerd
Journal:  Pharm Res       Date:  2007-07-06       Impact factor: 4.200

3.  Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections.

Authors:  Mohd Aftab Alam; Farhan Jalees Ahmad; Zeenat Iqbal Khan; Roop Krishen Khar; Mushir Ali
Journal:  AAPS PharmSciTech       Date:  2007-12-14       Impact factor: 3.246

4.  Magnetic resonance imaging and image analysis for assessment of HPMC matrix tablets structural evolution in USP Apparatus 4.

Authors:  Piotr Kulinowski; Przemysław Dorożyński; Anna Młynarczyk; Władysław P Węglarz
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.